Breaking News

Forge Biologics Receives Qualified Person Declaration to Manufacture AAV Gene Therapies

Fulfills EMA GMP manufacturing and declaration to support clients intending to export gene therapy products for clinical programs in Europe.

Forge Biologics, a manufacturer of genetic medicines, announced that its manufacturing facility has successfully completed the audits necessary and received QP declaration for its gene therapy manufacturing facility, thereby fulfilling the EU Good Manufacturing Practices (GMP) requirement to manufacture investigational medicinal products and allowing Forge to support European-based clinical trials. “QP declaration enhances Forge’s position as a leading global AAV manufacturer able to support ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters